First Time Loading...

agilon health inc
NYSE:AGL

Watchlist Manager
agilon health inc Logo
agilon health inc
NYSE:AGL
Watchlist
Price: 5.62 USD 4.46%
Updated: Apr 19, 2024

EBITDA Margin
agilon health inc

-4.9%
Current
-10%
Average
8.3%
Industry
Negative for the last year
-4.9%
Negative average
-10%
Better than average
Worse than industry value

EBITDA Margin Across Competitors

EBITDA Margin Comparison
agilon health inc Competitors

Country Company Market Cap EBITDA
Margin
US
agilon health inc
NYSE:AGL
2.3B USD
-5%
US
Cigna Corp
NYSE:CI
102.8B USD
6%
US
Cigna Group
XMUN:CGN
95.5B EUR
6%
US
CVS Health Corp
NYSE:CVS
89.8B USD
4%
DE
Fresenius Medical Care AG
XMUN:FME
20.8B EUR
16%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.8B USD
14%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.2B EUR
12%
US
Quest Diagnostics Inc
NYSE:DGX
14.3B USD
19%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
16%
US
DaVita Inc
NYSE:DVA
11.3B USD
19%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
-20%
agilon health inc
NYSE:AGL
Country US
Market Cap 2.3B USD
EBITDA Margin
-5%
Cigna Corp
NYSE:CI
Country US
Market Cap 102.8B USD
EBITDA Margin
6%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 95.5B EUR
EBITDA Margin
6%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 89.8B USD
EBITDA Margin
4%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 20.8B EUR
EBITDA Margin
16%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 16.8B USD
EBITDA Margin
14%
F
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 15.2B EUR
EBITDA Margin
12%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 14.3B USD
EBITDA Margin
19%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 10.8B EUR
EBITDA Margin
16%
DaVita Inc
NYSE:DVA
Country US
Market Cap 11.3B USD
EBITDA Margin
19%
Oak Street Health Inc
NYSE:OSH
Country US
Market Cap 9.5B USD
EBITDA Margin
-20%

Profitability Report

View the profitability report to see the full profitability analysis for agilon health inc.

Full Profitability Report

See Also

Summary
AGL intrinsic value, competitors valuation, and company profile.
DCF Valuation
AGL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AGL stock valuation using valuation multiples.
Wall Street Estimates
AGL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AGL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is EBITDA Margin?
What is the EBITDA Margin of agilon health inc?

Based on agilon health inc's most recent financial statements, the company has EBITDA Margin of -4.9%.

ALPHA SPREAD
Join more than 129,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.